Crossmark

Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo

Crossref DOI link: https://doi.org/10.1186/s41065-024-00351-x

Published Online: 2024-11-27

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tang, Lingxue

Ruan, Yiling

Wang, Beibei

Zhang, Mingjun

Xue, Jie

Wang, Tong https://orcid.org/0000-0002-1828-5935
Funding

Funding for this research was provided by:

Discipline Construction Funds of Wang Tong (2021LCZD15)

Natural Science Foundation of Hefei (2022034)
License Information

Text and Data Mining valid from 2024-11-27

Version of Record valid from 2024-11-27
More Information

Article History

Received: 12 September 2024

Accepted: 19 November 2024

First Online: 27 November 2024

Declarations

:

: This study was approved by the Ethics Committee of Anhui Medical University (No. LLSC20232217) to ensure that the research process and results meet ethical standards and codes of ethics.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below